Skip to main content

Table 1 Demographic, parasitological and clinical parameters, malaria treatment trial, Malo Island, Vanuatu, Feb-May 2005 (n = 54)

From: Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu

 

Treatment Group

Variable

CQ for Pv

CQ+SP for Pf

Number of participants

21

33

Male : Female

7:14

18:55

Median age in years (range)

11 (5-53)

12 (5-51)

Mean weight in kg (range)

36.1 (15-80)

38.5 (16-66)

Spleen rate in children age 2-9 years (%)

1/15 (5%)

3/24 (9%)

Haemoglobin < 10 g/dl (%)

0 (0%)

1 (3%)

Temperature > 37.5°C (%)

7 (33%)

13 (39%)

Self-reported signs and symptoms* (%)

14 (67%)

31 (94%)

Geometric mean of parasite density/μl (range)

877 (499-1540)

5224 (3242-8418)

  1. *Fever, rigors, headache, myalgia/arthralgia, nausea/vomiting, abdominal pain, and/or diarrhoea